Contraception Clinical Trial
Official title:
Classic vs. Uterine Sound-sparing Approach for Insertion of Copper T380A Intrauterine Device
The intrauterine devices are a safe, reliable, long-acting and reversible contraceptive
method. It is also sound safe and cheap contraceptive methods available and is nearly
maintenance free for up to 10 years.
The fear and the pain associated with intrauterine devices insertion consider barriers to
using this contraception method, this is because that the mucosal lining of female genital
tract is highly sensitive to touch and pain. However; most of small procedures done in this
sensitive area are performed without analgesia.
The pain during intrauterine devices insertion is due to application of the tenaculum ,
traction of the cervical canal, passing the uterine sound, insertion of the intrauterine
devices through the cervix, and irritation of the endometrial lining by the intrauterine
devices .
Previous studies have reported different lines to decrease pain during intrauterine device
insertion starting by simple methods such as pre-insertion ibuprofen use, intracervical or
intrauterine lidocaine and misoprostol up to paracervical blocks.
Previous studies, in literature, have found that the most painful steps during intrauterine
devices insertion were uterine sounding then intrauterine device insertion itself, followed
by tenaculum placement. One recent study addressed pain effect using an atraumatic vulsellum
and a single-tooth tenaculum on pain perception during intrauterine devices and found no
difference in reported pain.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
| Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
| Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
| Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
| Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
| Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
| Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
| Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
| Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
| Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
| Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
| Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
| Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
| Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
| Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
| Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
| Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |